Zodiac JRD MKJ Fund Raise of ₹40 Cr

Zodiac JRD MKJ Capital Structure Change

Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.

Value

₹40.00 Cr

Zodiac JRD MKJ Capital Structure Change

Zodiac-JRD-MKJ received BSE in-principle approval for its Rights Issue and has convened a board meeting on 4 November 2026 to fix the issue price and record date. The issue was earlier approved for up to Rs 40 Crore.

Zodiac JRD MKJ Q2 FY27 Results: Net Profit ₹1 Cr, Up 100.0% YoY

Zodiac JRD MKJ Ltd reported revenue from operations of ₹10.3 Cr (+0.0% YoY) and net profit of ₹1 Cr (+100.0% YoY) for Q2 FY27.

Key figure

Net profit ₹1 Cr · +100.0% YoY

Zodiac JRD MKJ Board Meeting Date

Zodiac-JRD-MKJ will hold a board meeting on 3 November 2026. It will consider unaudited financial results for the quarter and half year ended 30 September 2026.

Zodiac JRD MKJ Other Announcement

Zodiac-JRD-MKJ Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reflects changes in the promoter list due to reclassification and death.

Zodiac JRD MKJ Other Announcement

Zodiac-JRD-MKJ Ltd has re-appointed Girish L. Shethia as Statutory Auditor for a term of 60 months. This is a routine administrative compliance.

Pajson Agro India Fund Raise of ₹354.5 Cr

Pajson Agro's board approved a Rs.354.52 Crore preferential issue of 1,20,58,397 equity shares at Rs.294 each. Shareholder approval is sought at a meeting on 04-12-2026.

Value

₹354.5 Cr

Evonile Pharma Fund Raise of ₹900 Cr

Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.

Value

₹900.0 Cr

Lloyds Metals & Energy Fund Raise

Lloyds Metals and Energy's board approved a fund raise, with the mode of financing yet to be decided. Investors should watch for the eventual issuance structure and size.

Shlokka Dyes Fund Raise of ₹24.5 Cr

Shlokka Dyes board approved a ₹24.50 Crore preferential issue of equity shares and warrants. Shareholder approval is pending at a November 28, 2026 meeting.

Value

₹24.50 Cr

Crescentis Capital Fund Raise of ₹79.62 Cr

Crescentis Capital's board approved the Letter of Offer for a rights issue of 1,02,08,129 shares at Rs.78 each. The issue aggregates to Rs.7,962.34 lakhs, or about Rs.79.62 Crore, assuming full subscription.

Value

₹79.62 Cr

Execution

Issue opening November 16, 2026; closing November 27, 2026; listing on or about December 3, 2026

Acetech E-Commerce Fund Raise of ₹40 Cr

Acetech E-Commerce approved a ₹40 Crore Rights Issue and 70% acquisition of Unique Cookware (₹10.41 Crore). Both decisions will fund expansion into cookware and allied products.

Value

₹40.00 Cr